- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Micha Nandaraj Gallo
News 5 results
Cases & Deals
May 23, 2024
King & Spalding Secures Victory for Boehringer Ingelheim in First Zantac-Related Trial
In the News · Source: Law360
December 22, 2023
Mark Sentenac, Micha Gallo and Simran Modi’s article, “Mitigating Risks of Developing Drugs and Devices With AI” is named a Law360 top guest article of 2023
In the News · Source: Law360
Events 5 results
Webinar
March 29, 2024
The Machines Are Coming (And Lawsuits Too): Mitigating Risks of Product Design, Manufacture, and Sale Amidst the AI Revolution
Conference
November 7, 2023
Pharmaceutical University 2023
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Speaking Engagement
September 7, 2023
King & Spalding’s Cross-Disciplinary Life Sciences Team to Present on AI at the 16th Annual Medical Device Summit
Insights 1 results
Article · Source: Law360
July 6, 2023
Mitigating Risks Of Developing Drugs And Devices With AI